BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38015832)

  • 1. A network-based transcriptomic landscape of HepG2 cells uncovering causal gene-cytotoxicity interactions underlying drug-induced liver injury.
    Wijaya LS; Gabor A; Pot IE; van de Have L; Saez-Rodriguez J; Stevens JL; Le Dévédec SE; Callegaro G; van de Water B
    Toxicol Sci; 2024 Feb; 198(1):14-30. PubMed ID: 38015832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human hepatocyte TXG-MAPr: gene co-expression network modules to support mechanism-based risk assessment.
    Callegaro G; Kunnen SJ; Trairatphisan P; Grosdidier S; Niemeijer M; den Hollander W; Guney E; Piñero Gonzalez J; Furlong L; Webster YW; Saez-Rodriguez J; Sutherland JJ; Mollon J; Stevens JL; van de Water B
    Arch Toxicol; 2021 Dec; 95(12):3745-3775. PubMed ID: 34626214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of the NRF2 transcriptional network and its response to chemical insult in primary human hepatocytes: implications for prediction of drug-induced liver injury.
    Copple IM; den Hollander W; Callegaro G; Mutter FE; Maggs JL; Schofield AL; Rainbow L; Fang Y; Sutherland JJ; Ellis EC; Ingelman-Sundberg M; Fenwick SW; Goldring CE; van de Water B; Stevens JL; Park BK
    Arch Toxicol; 2019 Feb; 93(2):385-399. PubMed ID: 30426165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
    Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
    Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury.
    Oda S; Uchida Y; Aleo MD; Koza-Taylor PH; Matsui Y; Hizue M; Marroquin LD; Whritenour J; Uchida E; Yokoi T
    Arch Toxicol; 2021 Jan; 95(1):149-168. PubMed ID: 32816093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNFα-mediated hepatotoxicity.
    Fredriksson L; Wink S; Herpers B; Benedetti G; Hadi M; de Bont H; Groothuis G; Luijten M; Danen E; de Graauw M; Meerman J; van de Water B
    Toxicol Sci; 2014 Jul; 140(1):144-59. PubMed ID: 24752500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The integrated stress response-related expression of CHOP due to mitochondrial toxicity is a warning sign for DILI liability.
    Vlasveld M; Callegaro G; Fisher C; Eakins J; Walker P; Lok S; van Oost S; de Jong B; Pellegrino-Coppola D; Burger G; Wink S; van de Water B
    Liver Int; 2024 Mar; 44(3):760-775. PubMed ID: 38217387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity.
    Herpers B; Wink S; Fredriksson L; Di Z; Hendriks G; Vrieling H; de Bont H; van de Water B
    Arch Toxicol; 2016 May; 90(5):1163-79. PubMed ID: 26026609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput confocal imaging of differentiated 3D liver-like spheroid cellular stress response reporters for identification of drug-induced liver injury liability.
    Hiemstra S; Ramaiahgari SC; Wink S; Callegaro G; Coonen M; Meerman J; Jennen D; van den Nieuwendijk K; Dankers A; Snoeys J; de Bont H; Price L; van de Water B
    Arch Toxicol; 2019 Oct; 93(10):2895-2911. PubMed ID: 31552476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of omics-based human liver platforms for investigating the mechanism of drug-induced hepatotoxicity in vitro.
    Jiang J; Pieterman CD; Ertaylan G; Peeters RLM; de Kok TMCM
    Arch Toxicol; 2019 Nov; 93(11):3067-3098. PubMed ID: 31586243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CREB is a potential marker associated with drug-induced liver injury: Identification and validation through transcriptome database analysis.
    Zhang Q; Taniguchi S; So K; Tsuda M; Higuchi Y; Hashida M; Yamashita F
    J Toxicol Sci; 2022; 47(8):337-348. PubMed ID: 35922923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contextualization of causal regulatory networks from toxicogenomics data applied to drug-induced liver injury.
    Trairatphisan P; de Souza TM; Kleinjans J; Jennen D; Saez-Rodriguez J
    Toxicol Lett; 2021 Oct; 350():40-51. PubMed ID: 34229068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Identification of Pivotal Transcriptional Factors Mediating Cell Responses to Drugs With Drug-Induced Liver Injury Liabilities.
    Shah F; Medvedev A; Wassermann AM; Brodney M; Zhang L; Makarov S; Stanton RV
    Toxicol Sci; 2018 Mar; 162(1):177-188. PubMed ID: 29106686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of hepatic transcriptome profiling between acute liver injury and acute liver failure induced by acetaminophen in mice.
    Li C; Ming Y; Hong W; Tang Y; Lei X; Li X; Mao Y
    Toxicol Lett; 2018 Feb; 283():69-76. PubMed ID: 29174983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic imaging of adaptive stress response pathway activation for prediction of drug induced liver injury.
    Wink S; Hiemstra SW; Huppelschoten S; Klip JE; van de Water B
    Arch Toxicol; 2018 May; 92(5):1797-1814. PubMed ID: 29502165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
    Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
    Front Immunol; 2021; 12():789317. PubMed ID: 34975885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative gene and protein expression analyses of a panel of cytokines in acute and chronic drug-induced liver injury in rats.
    Hanafusa H; Morikawa Y; Uehara T; Kaneto M; Ono A; Yamada H; Ohno Y; Urushidani T
    Toxicology; 2014 Oct; 324():43-54. PubMed ID: 25051504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of temporal single cell cellular stress response activity with logic-ODE modeling reveals activation of ATF4-CHOP axis as a critical predictor of drug-induced liver injury.
    Wijaya LS; Trairatphisan P; Gabor A; Niemeijer M; Keet J; Alcalà Morera A; Snijders KE; Wink S; Yang H; Schildknecht S; Stevens JL; Bouwman P; Kamp H; Hengstler J; Beltman J; Leist M; Le Dévédec S; Saez-Rodriguez J; van de Water B
    Biochem Pharmacol; 2021 Aug; 190():114591. PubMed ID: 33957093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
    Eun JW; Bae HJ; Shen Q; Park SJ; Kim HS; Shin WC; Yang HD; Jin CY; You JS; Kang HJ; Kim H; Ahn YM; Park WS; Lee JY; Nam SW
    J Appl Toxicol; 2015 Feb; 35(2):152-64. PubMed ID: 25231249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic transcriptome-based comparison of cellular adaptive stress response activation networks in hepatic stem cell-derived progeny and primary human hepatocytes.
    Ter Braak B; Niemeijer M; Boon R; Parmentier C; Baze A; Richert L; Huppelschoten S; Wink S; Verfaillie C; van de Water B
    Toxicol In Vitro; 2021 Jun; 73():105107. PubMed ID: 33545341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.